rxstat › Classes › Antidepressants
Antidepressants: shortage status in Canada
17 of the 20 antidepressants rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Widespread shortageClomipramine3 of 4 reported products affected · est. return Jul 3, 2026Widespread shortageImipramine3 of 6 reported products affected · est. return Aug 28, 2026Partial shortageAmitriptyline15 of 34 reported products affected · est. return Jul 17, 2026Partial shortageBupropion3 of 15 reported products affected · est. return Jul 15, 2026Partial shortageCitalopram10 of 43 reported products affected · est. return Sep 30, 2026Partial shortageDesvenlafaxine2 of 17 reported products affected · est. return Jul 31, 2026Partial shortageDoxepin1 of 11 reported products affectedPartial shortageDuloxetine4 of 32 reported products affected · est. return Oct 10, 2026Partial shortageEscitalopram4 of 41 reported products affected · est. return Jul 20, 2026Partial shortageFluoxetine2 of 36 reported products affectedPartial shortageFluvoxamine1 of 10 reported products affected · est. return Aug 10, 2026Partial shortageMirtazapine2 of 24 reported products affected · est. return Jan 1, 2027Partial shortageParoxetine2 of 33 reported products affected · est. return Dec 18, 2026Partial shortageSertraline1 of 37 reported products affectedPartial shortageTrazodone2 of 17 reported products affected · est. return Aug 7, 2026Partial shortageTryptophan2 of 11 reported products affected · est. return Jun 26, 2026Partial shortageVenlafaxine9 of 47 reported products affected · est. return Dec 31, 2026No current shortageMoclobemideNo current shortageTrimipramineNo current shortageVortioxetine
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.